|
YALE COMPREHENSIVE CANCER CENTER
|
2P30CA016359-29
|
$1,871,000
|
EDELSON, RICHARD
|
YALE UNIVERSITY
|
|
WUMC-Cancer and Leukemia Group B
|
5U10CA077440-10
|
$334,381
|
BARTLETT, NANCY
|
WASHINGTON UNIVERSITY
|
|
Vitamin D and Ovarian Cancer Prevention and Treatment
|
5R01CA111334-03
|
$244,382
|
BAI, WENLONG
|
UNIVERSITY OF SOUTH FLORIDA
|
|
Virginia Mason Community Clinical Oncology Program
|
3U10CA035192-24S1
|
$80,000
|
Vuky, Jacqueline
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
Virginia Mason Community Clinical Oncology Program
|
5U10CA035192-24
|
$391,000
|
Vuky, Jacqueline
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
Viral Vectors in Tumors: Effects of Taxol and Radiation
|
5R01CA098706-05
|
$268,835
|
BOUCHER, YVES
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
VCU Minority-Based CCOP
|
3U10CA052784-17S1
|
$100,000
|
ROBERTS, JOHN
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
VCU Minority-Based CCOP
|
5U10CA052784-17
|
$527,332
|
ROBERTS, JOHN
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORT
|
5P30CA014089-32
|
$6,578,401
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
UPSTATE CAROLINA COMMUNITY CLINICAL ONCOLOGY PROGRAM
|
2U10CA035119-23
|
$1,740,827
|
BEARDEN, JAMES
|
SPARTANBURG REGIONAL MEDICAL CENTER
|
|
University of Texas MD Anderson SPORE in Ovarian Cancer
|
5P50CA083639-08
|
$2,249,522
|
BAST, ROBERT
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
University of Rochester Cancer Center CCOP Research Base
|
3U10CA037420-23S1
|
$146,724
|
Morrow, Gary
|
UNIVERSITY OF ROCHESTER
|
|
University of Rochester Cancer Center CCOP Research Base
|
5U10CA037420-23
|
$1,131,018
|
Morrow, Gary
|
UNIVERSITY OF ROCHESTER
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-20S2
|
$59,280
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-20S3
|
$114,000
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
5P30CA046592-20
|
$5,929,129
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
University of Michigan Comprehensive Cancer Center CCOP*
|
3U10CA074648-06S1
|
$14,723
|
Brenner, Dean
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
University of Iowa CALGB Institutional Grant
|
5U10CA047642-20
|
$119,291
|
VAENA, DANIEL
|
UNIVERSITY OF IOWA
|
|
University of Colorado Southwest Oncology Group
|
2U10CA042777-20
|
$82,102
|
ELIAS, ANTHONY
|
UNIVERSITY OF COLORADO DENVER/HSC AURORA
|
|
University of Colorado Southwest Oncology Group
|
3U10CA042777-20S1
|
$356,613
|
ELIAS, ANTHONY
|
UNIVERSITY OF COLORADO DENVER/HSC AURORA
|
|
Univ.of Calif., Irvine Cancer Center Support Grant
|
3P30CA062203-13S1
|
$68,952
|
MEYSKENS, FRANK
|
UNIVERSITY OF CALIFORNIA IRVINE
|
|
Univ.of Calif., Irvine Cancer Center Support Grant
|
3P30CA062203-13S2
|
$2,553,879
|
MEYSKENS, FRANK
|
UNIVERSITY OF CALIFORNIA IRVINE
|
|
Univ.of Calif., Irvine Cancer Center Support Grant
|
3P30CA062203-13S3
|
$59,791
|
MEYSKENS, FRANK
|
UNIVERSITY OF CALIFORNIA IRVINE
|
|
Understanding resistance to HER family tyrosine kinase inhibitors
|
1R01CA122216-01A1
|
$329,682
|
MOASSER, MARK
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
UCCRC -Cancer Center Support Grant
|
3P30CA014599-32S2
|
$3,773,055
|
LE BEAU, MICHELLE
|
UNIVERSITY OF CHICAGO
|
|
UCCRC -Cancer Center Support Grant
|
3P30CA014599-32S3
|
$78,561
|
LE BEAU, MICHELLE
|
UNIVERSITY OF CHICAGO
|
|
U10 Ful Member Application Affiliated with SWOG
|
5U10CA105409-04
|
$229,230
|
LIPPMAN, SCOTT
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Tumor-priming Microparticles for Pancreatic Cancer
|
5R44CA103133-04
|
$565,979
|
LU, ZE
|
OPTIMUM THERAPEUTICS, LLC
|
|
Treatment of Malignant Gliomas with 2-5A-anti-hTR
|
5R01CA108558-04
|
$293,510
|
BOGLER, OLIVER
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
TRANSLATIONAL RESEARCH IN CANCER
|
3P30CA056036-08S2
|
$4,309,306
|
Pestell, Richard
|
THOMAS JEFFERSON UNIVERSITY
|
|
TRANSLATIONAL RESEARCH IN CANCER
|
3P30CA056036-08S3
|
$57,159
|
Pestell, Richard
|
THOMAS JEFFERSON UNIVERSITY
|
|
Translational Research in Breast Cancer
|
3P50CA058183-13S1
|
$153,479
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Translational Research in Breast Cancer
|
5P50CA058183-13
|
$2,612,827
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Total Synthesis and Biosynthesis of Bioactive Substances
|
5R01CA070375-11
|
$203,525
|
WILLIAMS, ROBERT
|
COLORADO STATE UNIVERSITY-FORT COLLINS
|
|
TOLEDO COMMUNITY CLINICAL ONCOLOGY PROGRAM
|
5U10CA035415-24
|
$791,551
|
SCHAEFER, PAUL
|
TOLEDO COMMUNITY HOSPITAL ONCOLOGY PROG
|
|
Thermally Targeted Delivery of DOX
|
1R43CA126318-01A1
|
$179,980
|
BUDDE, RAYMOND
|
HOUSTON PHARMACEUTICALS, INC.
|
|
The Siteman Center of Cancer Nanotechnology Excellence *
|
5U54CA119342-03
|
$3,266,643
|
WICKLINE, SAMUEL
|
WASHINGTON UNIVERSITY
|
|
The Role of NF-kappaB in Chemotherapy Resistance
|
5R01CA098871-03
|
$340,162
|
CUSACK, JAMES
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
The role of JNK in Mammary tumor development
|
5R01CA100238-05
|
$278,349
|
VAN DEN BERG, CARLA
|
UNIVERSITY OF TEXAS AUSTIN
|
|
The Robert H.Lurie Comprehensive Cancer Center
|
3P30CA060553-13S5
|
$90,600
|
ROSEN, STEVEN
|
NORTHWESTERN UNIVERSITY
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
2P30CA060553-14
|
$5,033,724
|
ROSEN, STEVEN
|
NORTHWESTERN UNIVERSITY
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-14S1
|
$216,819
|
ROSEN, STEVEN
|
NORTHWESTERN UNIVERSITY
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-14S2
|
$66,034
|
ROSEN, STEVEN
|
NORTHWESTERN UNIVERSITY
|
|
The Ohio State University Comprehensive Cancer Center-Supplement
|
3P30CA016058-32S1
|
$232,765
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
The Ohio State University Comprehensive Cancer Center
|
3P30CA016058-32S2
|
$84,897
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
The Ohio State University Comprehensive Cancer Center
|
5P30CA016058-32
|
$3,716,537
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
The MIT-Harvard Center of Cancer Nanotechnology Excelle*
|
5U54CA119349-03
|
$3,928,266
|
LANGER, ROBERT
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
The Gulf Coast MBCCOP
|
1U10CA128536-01
|
$400,000
|
SCHWARZENBERGER, PAUL
|
SACRED HEART HEALTH SYSTEMS, INC.
|
|
The Evaluation of Novel Therapeutics for Genitourinary Malignancies
|
Z01 SC 010098
|
$257,641
|
Dahut, William
|
CCR (NCI)
|
|
The Apoptotic Role of MEKK1 in Cancer Chemotherapy
|
5R01CA100241-05
|
$257,383
|
CHENG, GENHONG
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|